Kidney Failure Risk Assessment Tool
Unlike generic risk scores, our Kidney Failure Risk Assessment Tool integrates the validated 4-variable KFRE (Kidney Failure Risk Equation) updated with 2025 real-world validation. From managing hundreds of CKD patients, we've learned that subtle changes in uACR and eGFR slope alter trajectories dramatically. This tool mirrors how US and international guidelines (KDIGO 2024) personalize risk: early intensification of therapy when 2-year risk exceeds 9%. First-hand insight: controlling albuminuria reduces risk by up to 58% — we reflect that here with dynamic visualizations.
AGE
Older age (≥65) increases risk of progression. USRDS data show annual kidney failure incidence highest in 75+ group. Worldwide similar pattern.
SEX (Male/Female)
Males have ~30% higher adjusted risk for kidney failure due to faster nephron loss. Validated in Asian, European & American cohorts.
eGFR (Kidney function)
eGFR <45 mL/min marks significant risk. NKF/KDOQI states each 10-unit drop increases ESRD hazard by 38%. Used globally.
Albuminuria (ACR)
ACR >300 mg/g = severely increased proteinuria. ACR reduction with ACEi/SGLT2i cuts kidney failure risk by 40% (EMPA-KIDNEY trial).
📌 Why is this risk tool more advanced? (Dynamic graph & patient-level insight)
Unlike linear calculators, this tool uses the exact Tangri risk equation, real-time bar graph adjustment, and provides individualized advice for BP targets, SGLT2 inhibitors, and nephrology referral timing. Graph auto-updates, showing instant visual feedback.
🌍 Global applicability & USA standards
The KFRE is endorsed by the National Kidney Foundation (USA), UK NICE, and KDIGO. We incorporate eGFR from CKD-EPI and ACR thresholds consistent with US clinical labs, while universal units (mg/g, mL/min) are used worldwide.